Login / Signup

Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI).

Oliver T StirrupGokhan TutMaria KrutikovDavid BoneTara LancasterBorscha AzmiIgor MonakhovPaul A H MossAndrew C HaywardAndrew CopasLaura J Shallcross
Published in: Wellcome open research (2024)
We found similar levels of anti-nucleocapsid antibody in residents and staff of LTCFs. Repeat infection and infection with an Omicron strain were associated with higher peak values. There was evidence of waning of anti-nucleocapsid antibody levels over time.
Keyphrases
  • long term care
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease